Clinical Efficacy of Erythropheresis in High Altitude Polycythemia
High Altitude Polycythemia
About this trial
This is an interventional treatment trial for High Altitude Polycythemia
Eligibility Criteria
Inclusion Criteria:
1. >=18 years old;2.High altitude polycythemia; 3.Han nationality who have been in highland for over 12 months; 4. No other complications indicated by general examinations such as chest X-ray, electrocardiogram; 5. patients who are informed and informed consent form are acquired.
Exclusion Criteria:
1. Hypoxemia caused by other respiratory or cardiac diseases or polycythemia vera; 2. Acute or subacute mountain sickness ; 3. Acute or chronic infections and medication history ; 4. Psychiatric disorders or severe neurosis; 5. Malignant myeloproliferative disease; 6. Any contraindications to erythropheresis.
Sites / Locations
- NO.953 HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Erythropheresis treatment
Routine treatment
Erythropheresis treatment was was added to routine treatment
Oxygen delivery and basic care